Dry eye syndrome: comprehensive etiologies and recent clinical trials
Abstract
Dry eye syndrome (DES) is multifactorial and likely to be a cause of concern more so than ever given the rapid pace of modernization, which is directly associated with many of the extrinsic causative factors. Additionally, recent studies have also postulated novel etiologies that may provide the basis for alternative treatment methods clinically. Such insights are especially important given that current approaches to tackle DES remains suboptimal. This review will primarily cover a comprehensive list of causes that lead to DES, summarize all the upcoming and ongoing clinical trials that focuses on treating this disease as well as discuss future potential treatments that can improve inclusivity.
Part of CIRS Nexus · Curated by Lauren Lowenstein, The Biotoxin Lady
Related Papers
- Multifaceted mitochondrial as a novel therapeutic target in dry eye: insights and interventionsCell Death Discovery · 2024 · 1 shared tag
- Decoding Allergic Conjunctivitis: Latest Perspectives on Etiological Drivers and Immunopathological MechanismsClinical Reviews in Allergy & Immunology · 2025 · 1 shared tag
- A Narrative Review of the Immunomodulatory Effects of Acthar® Gel Beyond Its Steroidogenic PropertiesAdvances in Therapy · 2025 · 1 shared tag
- Immunomodulatory Role of Neuropeptides in the CorneaBiomedicines · 2022 · 1 shared tag
- Novel Method for Assessing the Protection Lifetime of Building Coatings against FungiCoatings · 2023 · 1 shared tag
- In silico design of a TLR4-mediating multiepitope chimeric vaccine against amyotrophic lateral sclerosis via advanced immunoinformaticsJournal of Leukocyte Biology · 2022 · 1 shared tag